Coronary artery bypass graft disease

O N Nwasokwa1

  • 1Division of Cardiology, Harris Chasanoff Heart Institute, Long Island Jewish Medical Center, New Hyde Park, NY 11042, USA.

Insights

Saphenous vein graft disease is common after coronary artery bypass grafting, with 50% closing within 10 years. Using arterial grafts, like the internal mammary artery, significantly improves graft patency and patient outcomes.

Area of Science:

  • Cardiovascular Surgery
  • Vascular Biology
  • Medical Technology

Background:

  • Saphenous vein grafts are frequently used in coronary artery bypass grafting (CABG).
  • Vein grafts are susceptible to occlusive disease, primarily atherosclerosis, leading to graft failure.
  • Graft closure results in symptom recurrence and reduced long-term patient benefit.

Purpose of the Study:

  • To review the incidence and pathophysiology of saphenous vein graft disease.
  • To evaluate current strategies for the prevention of vein graft disease.
  • To discuss management options for failing saphenous vein grafts.

Main Methods:

  • Comprehensive literature search of MEDLINE database for studies on saphenous vein and arterial bypass grafts.
  • Focused selection of key studies from reference sections of relevant articles.
  • Extraction and synthesis of key findings related to graft outcomes and disease processes.

Main Results:

  • Saphenous vein graft failure is high, with 50% occlusion by 10 years post-CABG due to atherosclerosis.
  • Internal mammary artery grafts demonstrate superior patency rates (90% at >10 years) and are resistant to atherosclerosis.
  • Arterial grafts offer significant clinical advantages, including symptom relief, improved cardiac function, and increased survival.

Conclusions:

  • Prioritizing arterial grafts, such as the internal mammary artery, is crucial for preventing vein graft disease.
  • Minimizing endothelial injury during surgery and utilizing antiplatelet agents can reduce vein graft occlusion.
  • Reoperation for diseased grafts, particularly to the left anterior descending artery, can improve survival when arterial grafts are used.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...